These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 2845181
1. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications]. Greene DA, Sima AA, Lattimer SA. Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181 [No Abstract] [Full Text] [Related]
2. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. Greene DA, Lattimer SA, Sima AA. N Engl J Med; 1987 Mar 05; 316(10):599-606. PubMed ID: 3027558 [Abstract] [Full Text] [Related]
3. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus]. Mosiewicz J, Grzywa M. Pol Tyg Lek; 1987 Mar 05; 47(1-2):56-8. PubMed ID: 1329048 [Abstract] [Full Text] [Related]
4. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Greene DA, Lattimer SA, Sima AA. Diabetes; 1988 Jun 05; 37(6):688-93. PubMed ID: 2838351 [Abstract] [Full Text] [Related]
5. C-peptide, Na+,K(+)-ATPase, and diabetes. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. Exp Diabesity Res; 2004 Jun 05; 5(1):37-50. PubMed ID: 15198370 [Abstract] [Full Text] [Related]
6. High glucose levels induce inhibition of Na,K-ATPase via stimulation of aldose reductase, formation of microtubules and formation of an acetylated tubulin/Na,K-ATPase complex. Rivelli JF, Amaiden MR, Monesterolo NE, Previtali G, Santander VS, Fernandez A, Arce CA, Casale CH. Int J Biochem Cell Biol; 2012 Aug 05; 44(8):1203-13. PubMed ID: 22565168 [Abstract] [Full Text] [Related]
11. [Diabetic neuropathy--pathogenesis and precipitating factors]. Wasada T. Nihon Rinsho; 1991 Feb 05; 49 Suppl():159-65. PubMed ID: 1851896 [No Abstract] [Full Text] [Related]
12. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors. Madhu SV, Verma NP, Goel A, Kapoor VK. J Assoc Physicians India; 1992 Oct 05; 40(10):679-81. PubMed ID: 1307356 [No Abstract] [Full Text] [Related]
13. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy. Greene DA, Lattimer SA. Ann N Y Acad Sci; 1986 Oct 05; 488():334-40. PubMed ID: 3034118 [No Abstract] [Full Text] [Related]
14. Synergism between phospholipase D2 and sorbitol accumulation in diabetic cataract formation through modulation of Na,K-ATPase activity and osmotic stress. Huang P, Jiang Z, Teng S, Wong YC, Frohman MA, Chung SK, Chung SS. Exp Eye Res; 2006 Oct 05; 83(4):939-48. PubMed ID: 16797533 [Abstract] [Full Text] [Related]
15. The pathogenesis and prevention of diabetic neuropathy and nephropathy. Greene D. Metabolism; 1988 Feb 05; 37(2 Suppl 1):25-9. PubMed ID: 2828823 [Abstract] [Full Text] [Related]
16. The sorbitol pathway and the complications of diabetes. Gabbay KH. N Engl J Med; 1973 Apr 19; 288(16):831-6. PubMed ID: 4266466 [No Abstract] [Full Text] [Related]
17. Biochemical alterations and complications in diabetes. Greene DA, Lattimer SA. Clin Chem; 1986 Oct 19; 32(10 Suppl):B42-7. PubMed ID: 3019590 [No Abstract] [Full Text] [Related]